For ordering this report   For more information about this report  

 

A comprehensive study of the pharmaceutical material industry focusing on 38 selected chemical companies

Custom Synthesis Business for Life Science Industries in Japan 

 

Outline of the report

Comprehensive study was carried out in order to provide deep insights into the strategic business of active ingredients and intermediates manufacturers in Japan - from medium- to large-scale companies - offering custom synthesis services to leading international pharmaceutical companies.

Technological competence as well as both current and potential production capacities of each company are highlighted, with a particular focus on their competitiveness in the international market in terms of cost, product quality, environmental impact, and strengths in organic synthesis, biosynthesis and combined technology to manufacture chiral compounds.

The Product Lists contain specific types of custom synthesis being made available from each company surveyed, along with chemical structure of the compounds, pharmaceutical companies using those substances, and the drugs for which those materials are used.
Title of the report Custom Synthesis Business for Life Science Industries in Japan 
Date of issue 03/07/03
Volume A4 / 269 pages
Price 200,000JPY
Produced by Seed Planning, Inc.
Note $ 1,995 for orders from outside Japan
Category Pharmaceutical materials / vendors

Details of the report

Companies surveyed

Ajinomoto Co., Inc. API Corporation Asahi Glass Co., Ltd. Central Glass Co.,Ltd. Chisso Corporation Daicel Chemical Industries, Ltd. Daiichi Fine Chemicals Co., Ltd. Daikin Industries, Ltd. Daiso Co., Ltd. Hokko Chemical Industry Co., Ltd. Ihara Chemical Industry Co., Ltd. Kaneka Chemical Industry, Co. Ltd. Koei Chemical Co., Ltd. Kuraray Co., Ltd. Kyowa Hakko Kogyo Co., Ltd. Mercian Corporation Mitsubishi Rayon Co., Ltd. Mitsui Chemicals, Inc. New Japan Chemical Co., Ltd. Nissan Chemical Industries.,Ltd. Nippon Fine Chemical Co., Ltd. Nippon Kayaku Co., Ltd. Nippon Nohyaku Co., Ltd. Nippon Shokubai Co., Ltd. Nippon Soda Co., Ltd. Nisshin Pharma Inc. Otsuka Chemical Co., Ltd. Shin-Etsu Chemical Co., Ltd. Soda Aromatic Co., Ltd. Sumika Fine Chemicals Co., Ltd. Sumikin Air Water Chemical Inc. Sumitomo Chemical Co., Ltd. Sumitomo Seika Chemicals Co., Ltd. Takasago International Corp. Tosoh Corporation The Nippon Synthetic Chemical Industry Co., Ltd. Ube Industries, Ltd. Yuki Gosei Kogyo Co., Ltd.

The contents

1. Introduction


2. Summary


3. Case study (38 medium to large selected companies)
Headquarters
Contact
Company Profile
Founded
Capital
Employees
Major shareholders
Performance for Fiscal 2002: Non-consolidated (consolidated)
Total sales
R&D expenditures
Net income
Total asset
Cash flow from operational activities
Performance data by business/activity
Core products and technologies related to pharmaceuticals
Subsidiaries and affiliates related to pharmaceuticals (% invested)
Performance of the Business with the Pharmaceutical Industry
Areas of Competence
Factories and Major Facilities
Plant
1) Custom synthesis (cGMP-compliant)
2) Pilot facilities
3) Investigational drug production facilities
Key Products (Pharmaceuticals)
Market Research Report Electronics/IT Medical/biotechnology Health/nursing care/wellness

SPI-information is a website for SP Information selling marketing research reports produced in Japan and worldwide.